1. Harwood TR, Gracey DR, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol. 1976; 65:159–67.
Article
2. Attanoos RL, Gibbs AR. ‘Pseudomesotheliomatous’ carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology. 2003; 43:444–52.
Article
3. Koss MN, Fleming M, Przygodzki RM, Sherrod A, Travis W, Hochholzer L. Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases. Ann Diagn Pathol. 1998; 2:93–102.
Article
4. Vukovic´ J, Plavec G, Ac´imovic´ S, et al. Pseudomesotheliomatous carcinoma of the lung. Vojnosanit Pregl. 2016; 73:1168–72.
Article
5. Sakata S, Sakamoto Y, Takaki A, Ishizuka S, Saeki S, Fujii K. Reversible restrictive lung disease in pseudomesotheliomatous carcinoma in a lung harboring a HER2-mutation. Intern Med. 2018; 57:2223–6.
6. Rossi D, Bruscaggin A, Spina V, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood. 2011; 118:6904–8.
7. Jeon GW, Han SW, Jung JM, Kang MS, Sin JB. The first Korean case of cutaneous lung tissue heterotopia. J Korean Med Sci. 2010; 25:1387–9.
Article